Send feedback

INTS1 p.Val1128Met

c.3382G>A · rs200985889 · VCV3052788

Benign No assertion criteria
Classification
Benign
ClinVar
Review
No assertion criteria ☆☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely benign
0.3012 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0133%, afr)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
1
INTS1-related disorder

Computational evidence

Protein change
AlphaMissense0.3012likely benign
REVEL0.096moderately benign-leaning
SaProtLLR -7.97tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 4.8GERP 1.2, phastCons 1
Regional constrainto/e 0.96unconstrained · MANE · 21 kb · p 0.12 · regional, not allelic
Overall
CADD23.8PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0133% African / African-American · 10/74,928 alleles
Filtering AF 0.00986% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00921%
Overall 0.0244% 393/1,612,216 alleles · ultra-rare exomes 350/1,459,996 · genomes 43/152,220 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.679% 147
Remaining individualsnot grpmax-eligible 0.0481% 2,081
Finnishnot grpmax-eligible 0.0224% 4,473
African / African-Americangrpmax 0.0133% 7,493
European (non-Finnish) 0.0114% 8,739
Admixed American 0.00333% 29,995
South Asian 0.0011% 91,094

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
INTS1
Protein
p.Val1128Met
Coding
c.3382G>A
MANE Select
NM_001080453
dbSNP
rs200985889
Type
single nucleotide variant
Location
chr7:1484050 (GRCh38)
Gene constraint
LOEUF 0.785 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 75.49 · 8 PDB
Residue 1128
an α-helix
Full INTS1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

INTS1-related disorder

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ints1-p-val1128met (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown